The human epidermal growth factor receptor 2 (HER-2/neu) overexpression is observed in approximately 25–30% of all BC cases.1–4 HER2 receptor, a tyrosine kinase and oncogene, promotes oncogenesis through gene amplification and/or mutations. Here, ERBB2 is linked to breast cancer.